Revolutionizing T-cell Acute Lymphoblastic Leukemia (T-ALL) Treatment: A Novel Combination Therapy Offers New Hope Madelyn OlsenDecember 12, 2023Grant Announcement
PHASE ONE Foundation Welcomes Three New Board Members: Rebecca Cocco, Paula Selesnick, and Cindy Ruby Madelyn OlsenSeptember 22, 2023Foundation News
Unlocking New Hope: PHASE ONE Funds Phase I/II Trial Investigating a Novel Approach to Pediatric Cancer Treatment for Solid Tumors Madelyn OlsenSeptember 19, 2023Grant Announcement
PHASE ONE Funds Phase II Trial Using Biomarkers to Match Metastatic ER+ Breast Cancer Patients with Effective Treatments Madelyn OlsenJuly 27, 2023Grant Announcement
PHASE ONE’s 2023 Annual Gala Raises Over $1M for Clinical Cancer Research Madelyn OlsenMay 4, 2023Events, Foundation News
PHASE ONE Funds Imerman Angels’ Clinical Trial Matching Program Madelyn OlsenApril 6, 2023Grant Announcement
Grant Announcement for Phase II Study in Multiple Myeloma at USC Megan StubbsOctober 13, 2022Grant Announcement
Grant Announcement for Study Using NK Cells to Treat Ovarian Cancer at Dana-Farber Cancer Institute Megan StubbsSeptember 26, 2022Grant Announcement
PHASE ONE Funds Children’s Hospital Los Angeles Study of Novel Treatment for Osteosarcoma Megan StubbsNovember 16, 2021Grant Announcement
